Rasna Therapeutics has an EPS of $-0.01. In 2021, the company made an earnings per share (EPS) of $-0.01. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2022 | -$0.01 | 0.00% |
2021 | -$0.01 | -87.50% |
2020 | -$0.08 | - |